12/06/2026
Why choose between biological relevance and scale?
The Endo-GeneScreen platform offers both, using endogenous HiBiT tagging and bioluminescent detection to find meaningful hits in disease-relevant neurons.
Phenotypic screening keeps it biologically relevant. High-throughput screening keeps it scalable. Now you don't have to pick one.
We broke down how it works on the blog. 👉 https://ow.ly/2NWI50Z7R5Q